Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 393

1.

Factors associated with vancomycin-resistant enterococci colonization in a pediatric intensive care unit of Paraguay: A cross-sectional study on hospital charts.

Duarte L, Arbo A, Gallardo M, Riquelme I, Delgadillo L, Jiménez HJ.

Medwave. 2019 Sep 12;19(8):e7694. doi: 10.5867/medwave.2019.08.7694. Spanish, English.

PMID:
31596839
2.

Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.

Padovan ACB, Rocha WPDS, Toti ACM, Freitas de Jesus DF, Chaves GM, Colombo AL.

Fungal Genet Biol. 2019 Sep 9;133:103267. doi: 10.1016/j.fgb.2019.103267. [Epub ahead of print] Review.

PMID:
31513917
3.

Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.

Vickers ML, Malacova E, Milinovich GJ, Harris P, Eriksson L, Dulhunty JM, Cotta MO.

ANZ J Surg. 2019 Sep 3. doi: 10.1111/ans.15393. [Epub ahead of print]

PMID:
31480103
4.

Widespread antimicrobial resistance among bacterial infections in a Rwandan referral hospital.

Sutherland T, Mpirimbanyi C, Nziyomaze E, Niyomugabo JP, Niyonsenga Z, Muvunyi CM, Mueller A, Bebell LM, Nkubana T, Musoni E, Talmor D, Rickard J, Riviello ED.

PLoS One. 2019 Aug 23;14(8):e0221121. doi: 10.1371/journal.pone.0221121. eCollection 2019.

5.

Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.

Marimuthu K, Ng OT, Cherng BPZ, Fong RKC, Pada SK, De PP, Ooi ST, Smitasin N, Thoon KC, Krishnan PU, Ang MLT, Chan DSG, Kwa ALH, Deepak RN, Chan YK, Chan YFZ, Huan X, Zaw Linn K, Tee NWS, Tan TY, Koh TH, Lin RTP, Hsu LY, Sengupta S, Paterson DL, Perencevich E, Harbarth S, Teo J, Venkatachalam I; CaPES Study Group.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00845-19. doi: 10.1128/AAC.00845-19. Print 2019 Oct.

PMID:
31383670
6.

Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients.

Druge S, Ruiz S, Vardon-Bounes F, Grare M, Labaste F, Seguin T, Fourcade O, Minville V, Conil JM, Georges B.

J Intensive Care. 2019 Jul 19;7:36. doi: 10.1186/s40560-019-0390-4. eCollection 2019.

7.

What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review.

Sumi CD, Heffernan AJ, Lipman J, Roberts JA, Sime FB.

Clin Pharmacokinet. 2019 Jul 20. doi: 10.1007/s40262-019-00791-z. [Epub ahead of print] Review.

PMID:
31325141
8.

Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.

Boutrot M, Azougagh K, Guinard J, Boulain T, Barbier F.

J Antimicrob Chemother. 2019 Oct 1;74(10):3095-3103. doi: 10.1093/jac/dkz279.

PMID:
31289826
9.

Antibiotic Resistance in the Neonatal Intensive Care Unit.

Ramirez CB, Cantey JB.

Neoreviews. 2019 Mar;20(3):e135-e144. doi: 10.1542/neo.20-3-e135.

PMID:
31261051
10.

Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis.

Hu YJ, Ogyu A, Cowling BJ, Fukuda K, Pang HH.

Bull World Health Organ. 2019 Jul 1;97(7):486-501B. doi: 10.2471/BLT.18.225698. Epub 2019 May 14. Review. Erratum in: Bull World Health Organ. 2019 Aug 1;97(8):580.

11.

HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence-making intervention perspective.

Holt M, Newman CE, Lancaster K, Smith AK, Hughes S, Truong HM.

Sociol Health Illn. 2019 Jun 18. doi: 10.1111/1467-9566.12967. [Epub ahead of print]

PMID:
31215066
12.

Measurement of soft tissue drug concentrations in morbidly obese and non-obese patients - A prospective, parallel group, open-labeled, controlled, phase IV, single center clinical trial.

Simon P, Petroff D, Dorn C, Ehmann L, Kloft C, Prettin C, Dietrich A, Zeitlinger M, Kees F, Wrigge H.

Contemp Clin Trials Commun. 2019 May 10;15:100375. doi: 10.1016/j.conctc.2019.100375. eCollection 2019 Sep.

13.

Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.

Peters L, Olson L, Khu DTK, Linnros S, Le NK, Hanberger H, Hoang NTB, Tran DM, Larsson M.

PLoS One. 2019 May 8;14(5):e0215666. doi: 10.1371/journal.pone.0215666. eCollection 2019.

14.

Drug Prevention and Control of Ventilator-Associated Pneumonia.

Xie X, Lyu J, Hussain T, Li M.

Front Pharmacol. 2019 Mar 28;10:298. doi: 10.3389/fphar.2019.00298. eCollection 2019. Review.

15.

Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae.

Gao B, Li X, Yang F, Chen W, Zhao Y, Bai G, Zhang Z.

Front Pharmacol. 2019 Mar 22;10:262. doi: 10.3389/fphar.2019.00262. eCollection 2019.

16.

Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.

Zhou H, Yao Y, Zhu B, Ren D, Yang Q, Fu Y, Yu Y, Zhou J.

Medicine (Baltimore). 2019 Mar;98(13):e14937. doi: 10.1097/MD.0000000000014937.

17.

Comparison of Unyvero P55 Pneumonia Cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting.

Gadsby NJ, McHugh MP, Forbes C, MacKenzie L, Hamilton SKD, Griffith DM, Templeton KE.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1171-1178. doi: 10.1007/s10096-019-03526-x. Epub 2019 Mar 11.

PMID:
30859358
18.

Reduction of Contamination with Antibiotics on Surfaces and in Environmental Air in Three European Hospitals Following Implementation of a Closed-System Drug Transfer Device.

Sessink PJM, Nyulasi T, Haraldsson ELM, Rebic B.

Ann Work Expo Health. 2019 Apr 19;63(4):459-467. doi: 10.1093/annweh/wxz010.

PMID:
30852616
19.

Infections Caused by Carbapenemase-Producing Klebsiella pneumoniae: Microbiological Characteristics and Risk Factors.

Pan H, Lou Y, Zeng L, Wang L, Zhang J, Yu W, Qiu Y.

Microb Drug Resist. 2019 Mar;25(2):287-296. doi: 10.1089/mdr.2018.0339. Epub 2019 Feb 27.

20.

New Delhi metallo-β-lactamase-producing Acinetobacter isolates among late-onset VAP patients: multidrug-resistant pathogen and poor outcome.

Elbrolosy AM, Labeeb AZ, Hassan DM.

Infect Drug Resist. 2019 Feb 11;12:373-384. doi: 10.2147/IDR.S186924. eCollection 2019.

Supplemental Content

Loading ...
Support Center